EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $201 | -53.7% | 59 | 0.0% | 0.00% | – |
Q2 2023 | $434 | -97.2% | 59 | -96.0% | 0.00% | – |
Q1 2023 | $15,354 | -34.0% | 1,482 | -24.8% | 0.00% | -100.0% |
Q4 2022 | $23,278 | +1063.9% | 1,971 | +2042.4% | 0.00% | – |
Q3 2022 | $2,000 | -66.7% | 92 | -55.6% | 0.00% | – |
Q2 2022 | $6,000 | -25.0% | 207 | +3.5% | 0.00% | – |
Q1 2022 | $8,000 | -38.5% | 200 | -30.8% | 0.00% | – |
Q4 2021 | $13,000 | +62.5% | 289 | +75.2% | 0.00% | – |
Q3 2021 | $8,000 | +166.7% | 165 | +200.0% | 0.00% | – |
Q2 2021 | $3,000 | -50.0% | 55 | -16.7% | 0.00% | – |
Q1 2021 | $6,000 | -25.0% | 66 | -27.5% | 0.00% | – |
Q4 2020 | $8,000 | -63.6% | 91 | -57.1% | 0.00% | -100.0% |
Q3 2020 | $22,000 | +450.0% | 212 | +285.5% | 0.00% | – |
Q2 2020 | $4,000 | +100.0% | 55 | +27.9% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 43 | +22.9% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | – | 35 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |